DENA
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
08/06/2026
Back to search
Official data from USPTO
WISTA
This trademark appears in the official USPTO history.
Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILEDType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Case type
Application and registration
Recorded events
38
Latest update
08/06/2026
Trademark type
Word
Nice classes
5, 42
Filing date
12/22/2015
Registration date
03/07/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/23/2025
Last transaction
08/06/2026
Responsible office
United States Patent and Trademark Office
Status code
404
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
SG
Examiner
BAGLINI, KAREN
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
TauRx Therapeutics Ltd.
WisTa Laboratories Ltd
Representatives
Thad Chaloemtiarana Pattishall, McAuliffe, Newbury, Hilliard
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and medical preparations for use in the detectionprevention and treatment of neurological diseases and disordersneurodegenerative diseases and disordersblood disordersinfectious diseases and malaria; chemical preparations for medical and pharmaceutical purposes for use in the detectionprevention and treatment of neurological diseases and disordersneurodegenerative diseases and disordersblood disordersinfectious diseases and malaria; none of the aforesaid being pharmaceutical preparations and substances intended for the prevention and treatment of bone/skeletal diseases
Class 42
Medicalbiologicalbiotechnologicalgeneticpharmaceutical researchdesign and development services and laboratory research services in the fields of drugspharmaceuticals and medicines; researchdevelopment and design of drugs and medicine; drug discovery services; laboratory and medical laboratory research and development services relating to drugspharmaceuticals and medicines; exploitation of scientific research and technologyproviding advice and information relating to scientific and technological research in the fields of drugspharmaceuticals and medicinesin the fields of drug developmentclinical trial designpatient recruitmentdrug testingclinical data managementdata analysisstatistical analysispatient selectionclinical diagnosis and diagnostic testing; researching and developing new products in the fields of drugspharmaceuticals and medicines; scientific research and development services in the fields of drug developmentclinical trial designpatient recruitmentdrug testingclinical data managementdata analysisstatistical analysispatient selectionclinical diagnosis and diagnostic testing; preparation of reports of scientific and medical research concerning drugspharmaceuticalsmedicinesgeneticsbiology and biotechnology; development and design of medical or scientific prognostic and diagnostic apparatus and instruments; consultancy and information services relating to all of the aforesaid
Publications
History of USPTO decisions and trademark events.
38 publications found
DETH
DEATH OF INTERNATIONAL REGISTRATION
08/06/2026
CHLD
CHANGE OF OWNER RECEIVED FROM IB
11/20/2025
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
07/14/2024
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06/24/2024
INPC
INVALIDATION PROCESSED
06/24/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
06/14/2024
C71T
CANCELLED SECTION 71
09/22/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/07/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/08/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/19/2017
FIMP
FINAL DISPOSITION PROCESSED
06/19/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/07/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
03/07/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/20/2016
PUBO
PUBLISHED FOR OPPOSITION
12/20/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/30/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/16/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/05/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/03/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/03/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/03/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/06/2016
GNRT
NON-FINAL ACTION E-MAILED
10/06/2016
CNRT
NON-FINAL ACTION WRITTEN
10/06/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/15/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/15/2016
ALIE
ASSIGNED TO LIE
09/10/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/02/2016
RFNT
REFUSAL PROCESSED BY IB
05/13/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/15/2016
RFRR
REFUSAL PROCESSED BY MPU
04/15/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/15/2016
CNRT
NON-FINAL ACTION WRITTEN
04/14/2016
DOCK
ASSIGNED TO EXAMINER
04/11/2016
MAFR
APPLICATION FILING RECEIPT MAILED
02/27/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/23/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/22/2016
Continuous trademark protection
Get notified about every new filing that threatens WISTA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.